pharmaceutical intermediates farmasino

Lixisenatide (320367-13-3) controls blood sugar & weight in type 2 diabetes via enhanced insulin, delayed gastric emptying & appetite regulation. Ideal for oral medication non-responders. For R&D use only.

Survodutide is a dual GCGR/GLP-1R agonist for R&D. It increases energy expenditure, improves liver fibrosis, reduces appetite, and enhances satiety. White powder, CAS 2805997-46-8.

Carbetocin Acetate (1631754-28-3) is a white powder oxytocin receptor agonist. High purity, precise molecular weight (988.16–1048.21), for R&D use under patent.

Glatiramer acetate (147245-92-9) is a white powder immunomodulator for treating RRMS and CIS. High-purity (CAS: 147245-92-9, MF: C25H45N5O13) for R&D use under patent.

Sodium Dihydrogen Phosphate (89140-32-9) - 98% assay, anhydrous specification. Used as acidity regulator & antioxidant in food/pharma. 25kg/drum, 2-year shelf life.

Sodium Citrate (68-04-2), 98% assay, serves as an effective alkalizer and chelating agent in formulations. With a 2-year shelf life and 25kg/drum packaging, it ensures reliable performance and stability for industrial applications.

Blonanserin (132810-10-7) is an atypical antipsychotic SDA for schizophrenia. Available in CP/EP specs, 98% assay, 2-year shelf life. Custom specifications and bulk 25kg/drum packaging available.

Norepinephrine Bitartrate (CAS 69815-49-2), 99% assay. Compliant with CP/EP standards or custom specifications. Supports synaptic plasticity research with 2-year shelf life. Bulk 25kg/drum packaging.